Information on Interleukin-15

supercrunch1

New member
Hello to all at Muscle Chemistry. Some of you might know me from other boards. I am looking for info on Interleukin-15. I have read reports that lead me to believe it may be of interest for bodybuilding. I am sure someone has possibly used this before or experimented with it. In one study I read that when stacked with igf-1 its anabolic response was magnified up to 500%. Though this was with rats, it did peak my interests enough to start seeking more info. Let me know.

---supercrunch---
 
the new IL-15 bible

we've got a new drug showing up on the bodybuilding horizon, interleukin-15. it has generated a lot of excitement because of several in vitro -- think tissue in petrie dish -- studies demonstrating tremendous muscular hypertrophy. it's already available from several research companies, and some people have already hurt themselves badly using it. this post discusses the basics of what it is, how it might be useful, and why it isn't right now.

the quick answer is that interleukin-15 is not ready for primetime similar to how igf-i alone wasn't ready until modified to the lr3igf-i analog, and will lead to muscle loss and other very bad outcomes unless you use small amounts. something that makes your body produce it may be a good bodybuilding drug someday in small doses. IL-15 isn't a good bodybuilding drug right now.

the interleukin family is not really a set of hormones, but a set of cytokines instead. it's produced locally for the most part and it is really much more specific to immune system function, not muscle growth or cell growth in general. this is different from most of the muscle-building drugs we take, which are or emulate hormones and work more systemically.

il-15 in particular is very similar to il-2 and both seem to heavily modulate the attack functions of the immune response. its major systemic job is more to stimulate the growth of many different immune cells, including T, B, and TIL's. it also can be used to trigger and localize these attacks; if it's expressed in a given tissue killer NK cells will be more likely to come to and attack it.

in addition to these properties, though, it does indeed seem to act directly on skeletal muscle. this is really weird and wasn't expected. there's no obvious explanation for why it would be this way. it only leads to myotube hypertrophy (similar to androgens) and not myoblast proliferation or differentiation (similar to igf-i).

http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=14499665
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=12372339

it does seem to be make up a good part of the amount of "genetic potential" people have. studies have found variations in its production correlate highly with the degree to which people respond to resistance training:

http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=15531573

the $1,000 question is whether this translates to meaning that really high levels would mean a lot more muscle growth. the answer is "no, because you're going to make your body kill itself and/or your own muscle." using too much systemic IL-15 will cause random autoimmune diseases, such as arthritis or lupus. using too much of a drug targeted at intramuscular IL-15 in particular for too long would probably give you either myasthenia gravis or some form of idiopathic inflammatory myopathy, neither of which is very conducive to moving, and have a 5-year mortality rates above 20%. essentially, the high levels of il-15 will cause those killer immune cells to viciously attack your muscle.

http://rheumatology.oupjournals.org/cgi/content/full/40/8/876
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=14611115
http://intimm.oupjournals.org/cgi/content/full/14/8/917

so, small, targeted amounts may help, but you have to be very careful. i would never recommend systemic use, particularly when combined with insulin. the combination of these two will very likely cause your body to initiate thermonuclear warfare on your own pancreas leading to bad type 1 diabetes. a few people have already done this to themselves. there's also no guarantee it'll seep into muscle cells very well once it's in your system broadly. it has an extremely short serum half-life to boot.

http://www.jbc.org/cgi/content/full/272/4/2312

if you were determined to go ahead anyway, it would be preferable to use signalling cytokines or a monoclonal antibody similar to mAb35, both of which would trigger local intramuscular IL-15 production. this would be more targeted and interesting than direct systemic administration of il-15, which led to no net growth of muscle in healthy rats. to the contrary, it has been demonstrated in vivo that long-term use of this antibody can actually lead to permanent wasting of muscle because the immune system beats it to shreds. the one in which there was growth was in those with tumors, and given il-15's role in the immune system, this is a very bad population to look at whether it's useful for muscle growth in general.

http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=11585642
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=11287118
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=PubMed&list_uids=12690362&dopt=Abstract
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&dopt=Abstract&list_uids=10945502

if something stimulating muscular IL-15 production is ever used by bodybuilding, proper dosage will be critical to making it work, and it'll be pretty risky. it may be useful someday though.
 
Last edited:
I've already heard of people fuckin up their pancreas by using IL-15 and insulin stacked together, guess that's a no no, lol.
 
AWESOME post marble you answered all my questions plus! I have been looking for info for days and you put it all into laymans terms for me. I greatly appreciate your post. Well I guess its back to the old drawing board ;)
 
my pleasure to help out bro, really. :) do me a favour and repost this information in places you went looking for it with appropriate credit to marble and musclechemistry? it would be greatly appreciated to get the word out. i don't want any more people blowing themselves up. :(

huge thanks.
 
3 studies. IL-15 sounds actually as a safer alternative of IGF-1 for those concerned about cancer risks:

Interleukin-15: a novel anabolic cytokine for skeletal muscle.

Quinn LS, Haugk KL, Grabstein KH.

Geriatric Research, Education, and Clinical Center, American Lake VA Medical Center, Tacoma, WA 98493, USA.

Interleukin-15 (IL-15) is a recently discovered growth factor which is highly expressed in skeletal muscle. In order to determine a functional role for IL-15 in skeletal myogenesis, the effects of IL-15 on myoblast proliferation and muscle-specific myosin heavy chain (MHC) expression were analyzed using the mouse C2 skeletal myogenic cell line and primary fetal bovine skeletal myogenic cultures. IL-15 had no effect on [3H]thymidine incorporation, nor on the rate of myoblast differentiation, assessed by anti-MHC immunocytochemical staining, in either type of culture. However, Western blot analyses revealed that IL-15 used at concentrations of 10 or 100 ng/ml increased MHC accumulation five-fold in C2 myoblast cultures and 2.5-fold in primary bovine myogenic cultures. Moreover, C2 myotubes formed in the presence of IL-15 appeared larger than controls. These findings indicate IL-15 can stimulate differentiated myocytes and muscle fibers to accumulate increased amounts of contractile proteins. Well-fused primary bovine myogenic cultures treated with the mitotic inhibitor aphidicolin, then administered IL-15 and/or the anabolic growth factor insulin-like growth factor-I (IGF-I), were analyzed for MHC accumulation using Western blots. IL-15 used at 10 ng/ml doubled MHC accumulation and was as effective as IGF-I used at 10 or 100 ng/ml. IL-15 and IGF-I used together increased MHC accumulation close to five-fold, indicating these two factors can act additively on muscle fibers. These findings indicate IL-15 affects parameters associated with skeletal muscle fiber hypertrophy, and suggest that IL-15 may be a novel anabolic agent to increase skeletal muscle mass.

PMID: 7628408 [PubMed - indexed for MEDLINE]
(*)

Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses.

Riechman SE, Balasekaran G, Roth SM, Ferrell RE.

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, PA 15260, USA. [email protected]

Interleukin-15 (IL-15) is an anabolic cytokine that is produced in skeletal muscle and directly affects muscle anabolism in animal and in vitro models. The contribution of IL-15 variability in muscle responses to 10 wk of resistance exercise training in young men and women was examined by measuring acute and chronic changes in IL-15 protein in plasma and characterizing genetic variation in the IL-15 receptor-alpha gene (IL15RA). Participants trained 3 days a week at 75% of one repetition maximum, performing three sets (6-10 repetitions) of 13 resistance exercises. Plasma IL-15 protein was significantly increased (P < 0.05) immediately after acute resistance exercise but did not change with training and was not associated with variability in muscle responses with training. A single nucleotide polymorphism in exon 7 of IL15RA was strongly associated with muscle hypertrophy and accounted for 7.1% of the variation in regression modeling. A polymorphism in exon 4 was also independently associated with muscle hypertrophy and accounted for an additional 3.5% of the variation in hypertrophy. These results suggest that IL-15 is an important mediator of muscle mass response to resistance exercise training in humans and that genetic variation in IL15RA accounts for a significant proportion of the variability in this response.

PMID: 15531573 [PubMed - in process]

Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders.

Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argiles JM.

Division of Gerontology and Geriatric Medicine, University of Washington, Seattle 98195, USA. [email protected]

Interleukin-15 (IL-15) is a novel anabolic factor for skeletal muscle which inhibits muscle wasting associated with cancer (cachexia) in a rat model. To develop a cell culture system in which the mechanism of the anabolic action of IL-15 on skeletal muscle could be examined, the mouse C2 skeletal myogenic cell line was transduced with a retroviral expression vector for IL-15 and compared to sister cells transduced with a control vector. Overexpression of IL-15 induced fivefold higher levels of sarcomeric myosin heavy chain and alpha-actin accumulation in differentiated myotubes. Secreted factors from IL-15-overexpressing myogenic cells, but not from control cells, induced increased myofibrillar protein accumulation in cocultured control myotubes. IL-15 overexpression induced a hypertrophic myotube morphology similar to that described for cultured myotubes which overexpressed the well-characterized anabolic factor insulin-like growth factor-I (IGF-I). However, in contrast to IGF-I, the hypertrophic action of IL-15 on skeletal myogenic cells did not involve stimulation of skeletal myoblast proliferation or differentiation. IL-15 induced myotube hypertrophy at both low and high IGF-I concentrations. Furthermore, in contrast to IGF-I, which stimulated only protein synthesis under these culture conditions, IL-15 both stimulated protein synthesis and inhibited protein degradation in cultured skeletal myotubes. These findings indicate that IL-15 action on skeletal myogenic cells is distinct from that of IGF-I. Due to the ability of IGF-I to stimulate cell division and its association with several forms of cancer, controversy exists concerning the advisability of treating cachexia or age-associated muscle wasting with IGF-I. Administration of IL-15 or modulation of the IL-15 signaling pathway may represent an alternative strategy for maintaining skeletal muscle mass under these conditions.

PMID: 12372339 [PubMed - indexed for MEDLINE]

(* You can get the full text of this which is very interesting. Look at the graph when stacked with IGF-1. From the conclusions:
"The precise roles, mode of action, and regulation of expression of IL15 in skeletal muscle tissue remain to be defiid Unlike other anabolic agents such as anabolic steroids, GH, or IGF, which have multiple effects on a wide range of tissues, the effects of IL15 may be more tissue-specific. IL15 may therefore prove to be a useful agent for stimulating skeletal muscle growth or reversing skeletal muscle atrophy.")
 
IL-15 Activates Telomerase and Minimizes Telomere Loss and May Preserve the Replicative Life Span of Memory CD8+ T Cells In Vitro.

Li Y, Zhi W, Wareski P, Weng NP.

Laboratory of Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224.

The preservation of the replicative life span of memory CD8(+) T cells is vital for long-term immune protection. Although IL-15 plays a key role in the homeostasis of memory CD8(+) T cells, it is unknown whether IL-15 regulates the replicative life span of memory CD8(+) T cells. In this study, we report an analysis of telomerase expression and telomere length in human memory phenotype CD8(+) T cells maintained by IL-15 in vitro. We demonstrate that IL-15 is capable of activating telomerase in memory CD8(+) T cells via Jak3 and PI3K signaling pathways. Furthermore, IL-15 induces a sustained level of telomerase activity over long periods of time, and in turn minimizes telomere loss in memory CD8(+) T cells after substantial cell divisions. These findings suggest that IL-15 activates stable telomerase expression and compensates telomere loss in memory phenotype CD8(+) T cells, and that telomerase may play an important role in memory CD8(+) T cell homeostasis.




A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection.

Yajima T, Nishimura H, Sad S, Shen H, Kuwano H, Yoshikai Y.

Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. [email protected]

A rapid induction of effector functions in memory T cells provides rapid and intensified protection against reinfection. To determine potential roles of IL-15 in early expansion and activation of memory CD8+ T cells in secondary immune response, we examined the cell division and cytotoxicity of memory CD8+ T cells expressing OVA(257-264)/Kb-specific TCR that were transferred into IL-15-transgenic (Tg) mice, IL-15 knockout (KO) mice, or control C57BL/6 mice followed by challenge with recombinant Listeria monocytogenes expressing OVA (rLM-OVA). In vivo CTL activities and expression of granzyme B of the transferred CD8+ T cells were significantly higher in the IL-15 Tg mice but lower in the IL-15 KO mice than those in control mice at the early stage after challenge with rLM-OVA. In contrast, there was no difference in the cell division in IL-15 Tg mice and IL-15 KO mice compared with those in control mice. In vivo administration of rIL-15 conferred robust protection against reinfection via induction of granzyme B in the memory CD8+ T cells. These results suggest that IL-15 plays an important role in early activation of memory CD8+ T cells.






Interleukin-2, interleukin-15, and their roles in human natural killer cells.

Becknell B, Caligiuri MA.

Medical Scientist Program, USA.

Natural killer (NK) cells are CD56(+)CD3(-) large granular lymphocytes that constitute a key component of the human innate immune response. In addition to their potent cytolytic activity, NK cells elaborate a host of immunoregulatory cytokines and chemokines that play a crucial role in pathogen clearance. Furthermore, interactions between NK and other immune cells are implicated in triggering the adaptive, or antigen-specific, immune response. Interleukin-2 (IL-2) and IL-15 are two distinct cytokines with partially overlapping properties that are implicated in the development, homeostasis, and function of NK cells. This review examines the pervasive effects of IL-2 and IL-15 on NK cell biology, with an emphasis on recent discoveries and lingering challenges in the field.

PMID: 15705423 [PubMed - in process]




Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ.

Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Interleukin (IL)-21 is the most recently recognized of the cytokines that share the common cytokine receptor gamma chain (gamma(c)), which is mutated in humans with X-linked severe combined immunodeficiency. We now report that IL-21 synergistically acts with IL-15 to potently promote the proliferation of both memory (CD44high) and naive (CD44low) phenotype CD8+ T cells and augment interferon-gamma production in vitro. IL-21 also cooperated, albeit more weakly, with IL-7, but not with IL-2. Correspondingly, the expansion and cytotoxicity of CD8+ T cells were impaired in IL-21R-/- mice. Moreover, in vivo administration of IL-21 in combination with IL-15 boosted antigen-specific CD8+ T cell numbers and resulted in a cooperative effect on tumor regression, with apparent cures of large, established B16 melanomas. Thus, our studies reveal that IL-21 potently regulates CD8+ T cell expansion and effector function, primarily in a synergistic context with IL-15.

Note: CD8+ T cells are the same thing as cytotoxic t cells which play a large role in killing intracellular infections and releasing other important cytokines, stimulating an immune response.
 
please understand that a bunch of abstracts tossed in a pile does nobody any more service than a link to pubmed with IL-15 as a search string.

autoimmune diseases are some of the most crippling known. i wouldn't call the drug remotely safe, given that we haven't heard of anyone acquiring cancer from lr3igf-i use, and the role of igf-i in most cancers is controversial right now. however, several people have already badly damaged their bodies with IL-15. but look, i can copy-paste too:

Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control.

Carbo N, Lopez-Soriano J, Costelli P, Alvarez B, Busquets S, Baccino FM, Quinn LS, Lopez-Soriano FJ, Argiles JM.

Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Spain.

Interleukin (IL)-15 is a cytokine which is highly expressed in skeletal muscle. Cell culture studies have indicated that IL-15 may have an important role in muscle fiber growth and anabolism. However, data concerning the metabolic effects of this cytokine in vivo are lacking. In the present study, IL-15 was administered to adult rats for 7 days. While IL-15 did not cause changes in either muscle mass or muscle protein content, it induced significant changes in the fractional rates of both muscle protein synthesis and degradation, with no net changes in protein accumulation. Additionally, IL-15 administration resulted in a 33% decrease in white adipose tissue mass and a 20% decrease in circulating triacylglycerols; this was associated with a 47% lower hepatic lipogenic rate and a 36% lower plasma VLDL triacylglycerol content. The decrease in white fat induced by IL-15 was in adipose tissue. No changes were observed in the rate of lipolysis as a result of cytokine administration. These findings indicate that IL-15 has significant effects on both protein and lipid metabolism, and suggest that this cytokine may participate in reciprocal regulation of muscle and adipose tissue mass.

it's effective in a petry dish. it's effective in tumour-bearing mice. it's ineffective when applied systemically to adult mice. its overproduction is responsible for many horrible muscle-wasting diseases.
 
Last edited:
Back
Top